BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 9, 2021
View Archived Issues
Breaks are good for T-cell productivity, too
Read More
Premetastatic niche is prepared via leaky gut in colorectal cancer
Read More
Patient dosing starts in first-in-human study of DS-1594 as treatment of AML and ALL
Read More
IND application for JS-007 injection receives acceptance notice in Japan
Read More
Enrollment ongoing in phase II/III study of pyronaridine/artesunate for the treatment of COVID-19
Read More
Phase III COV-BARRIER study of baricitinib in COVID-19 does not meet primary endpoint
Read More
Phase II study of zanubrutinib in COVID-19 misses coprimary efficacy endpoints
Read More
Naphthalene monoimide TGR-63 for treating Alzheimer's disease
Read More
Allosteric MALT1 inhibitors from Toray Industries for the treatment of psoriasis
Read More
Bristol Myers Squibb reports positive topline data from phase III CheckMate-648 trial
Read More
FDA places partial clinical hold on first-in-human study of RVU-120
Read More
Indian researchers patent ENPP1 inhibitors
Read More
Novartis presents new KMT2A inhibitors
Read More
Vicore Pharma discloses AGTR2 agonists
Read More
Preliminary data from phase Ib trial of gedatolisib plus palbociclib and endocrine therapy
Read More
Roche synthesizes new TLR antagonists
Read More
VSIG4-targeting antibodies presented by Y-Biologics and Pierre Fabre Medicament
Read More
Phase II study of MIB-626 enrolling adults with Friedreich's ataxia
Read More
Dosing begins in phase I/II substudy of pembrolizumab in melanoma brain metastasis
Read More
Spinal cord stimulation reduces diabetic neuropathy pain
Read More
Enrollment begins in phase II study of ATR-002 in hospitalized patients with COVID-19
Read More
Bristol Myers Squibb starts enrolling patients in phase I study of BMS-986158 in myelofibrosis
Read More
Positive 12-month data presented from phase II TOPAZ study of apitegromab in SMA
Read More